Table 1.
YP transferred to the adult clinic (n = 78) | YP transferred to the adolescent JIA-clinic (n = 76) | |
---|---|---|
Transfer period | 2009–2015 | 2012–2015 |
Gender Female (%) | 71% | 56% |
Mean age (SD) at time of study inclusion | 22.2 (2.4) | 18.6 (2.3) |
Mean age (SD) at transfer | 17.8 (1.5) | 15.2 (2.1) |
Diagnosis (n / %) | ||
• JIA – oligoarticular | • 21 / 27 | • 26 / 37 |
• JIA – polyarticular | • 15 / 19 | • 21 /30 |
• JIA – PSA | • 3 / 4 | • 3 /4 |
• JIA – ERA | • 8 / 10 | • 7 /10 |
• SLE | • 15 / 19 | • 1 /2 |
• Other (e.g. GPA, FMF) | • 16 / 21 | • 12 /17 |
Disease activity before transfer (median, IQR) | ||
• Number of tender joints | • 0 (0–0) | • 0 (0–0) |
• Number of swollen joints | • 0 (0–0) | • 0 (0–0) |
• ESR | • 8 (3–17) | • 8 (3–15) |
Disease activity after transfer (median, IQR) |
||
• Number of tender joints | • 0.(0–0) | • 0 (0–1) |
• Number of swollen joints | • 0.(0–0) | • 0 (0–1) |
• ESR | • 9 (4–19) | • 8 (3–15) |
Abbreviations: JIA Juvenile Idiopathic Arthritis, PsA Psoriatic Arthritis, ERA Enthesitis Related Arthritis, SLE Systemic Lupus Erythematosus, GPA Granulomatosis with Polyangiitis, FMF Familial Mediterranean Fever